Since a cluster of infections was identified at Changi airport in May, experts said that the Delta variant has become the most prevalent strain of Covid-19 in Singapore.
In reaction, Singapore government authorities have subsequently moved back to stricter curbs on social gatherings and public activities, though it has begun relaxing some of those restrictions.
SINGAPORE — The list of people who had received China’s Sinovac Biotech (SVA.O) vaccine shots have been excluded from Singapore’s count of total vaccinations against Covid-19, according to officials in the city-state who cited inadequate efficacy data for the Chinese-made vaccine, especially against the contagious Delta variant.
“We don’t really have a medical or scientific basis or have the data now to establish how effective Sinovac is in terms of infection and severe illnesses on Delta,” Singapore’s health minister Ong Ye Kung says during a media briefing.
“Only people who participated in the national immunization program, which currently uses the Moderna and Pfizer-BioNTech/Cominarty (PFE.N), shots, are counted in the tally for vaccinations,” Ong syas.
More than 3.7 million Singaporeans have received at least one dose of the Pfizer or Moderna vaccines, covering about 65 percent of Singapore’s population and nearly 2.2 million have completed the two-dose regimen.
With the city-state targeting two-thirds of its people to be fully vaccinated by around 09 August and following an emergency use approval by the World Health Organization (WHO), Singapore began allowing designated private clinics to offer Sinovac’s CoronaVac since mid-June.
As of 03 July, just over 17,000 people had received one dose of CoronaVac and authorities say that demand for the vaccine appeared to taper off after an initial rush. The previous month, Singapore’s director of medical services Kenneth Mak cited that evidence from other countries showed people who had taken CoronaVac were still getting infected, posing a significant risk. (TRC/The MiNT)